FlowForge: A Staged Local Rollout Engine for Flow-Field Prediction

Deep learning surrogates for CFD flow-field prediction often rely on large, complex models, which can be slow and fragile when data are noisy or incomplete. We introduce FlowForge, a staged local rollout engine that predicts future flow fields by compiling a locality-preserving update schedule and executing it with a shared lightweight local predictor. Rather than producing the next frame in a single global pass, FlowForge rewrites spatial sites stage by stage so that each update conditions only on bounded local context exposed by earlier stages. This compile-execute design aligns inference with short-range physical dependence, keeps latency predictable, and limits error amplification from global mixing. Across PDEBench, CFDBench, and BubbleML, FlowForge matches or improves upon strong baselines in pointwise accuracy, delivers consistently better robustness to noise and missing observations, and maintains stable multi-step rollout behavior while reducing per-step latency.

Overview of the CXR-LT 2026 Challenge: Multi-Center Long-Tailed and Zero Shot Chest X-ray Classification

Chest X-ray (CXR) interpretation is hindered by the long-tailed distribution of pathologies and the open-world nature of clinical environments. Existing benchmarks often rely on closed-set classes from single institutions, failing to capture the prevalence of rare diseases or the appearance of novel findings. To address this, we present the CXR-LT 2026 challenge. This third iteration of the benchmark introduces a multi-center dataset comprising over 145,000 images from PadChest and NIH Chest X-ray datasets. The challenge defines two core tasks: (1) Robust Multi-Label Classification on 30 known classes and (2) Open-World Generalization to 6 unseen (out-of-distribution) rare disease classes. We report the results of the top-performing teams, evaluating them via mean Average Precision (mAP), AUROC, and F1-score. The winning solutions achieved an mAP of 0.5854 on Task 1 and 0.4315 on Task 2, demonstrating that large-scale vision-language pre-training significantly mitigates the performance drop typically associated with zero-shot diagnosis.